Yuzu Health has raised $35 million in Series A funding, led by General Catalyst and Chemistry, bringing its total funding to $40 million. The round also included participation from investors such as Anthropic’s Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom, and Neo. As part of the deal, General Catalyst’s Alex Tran will join Yuzu Health’s board, supporting the company’s next phase of growth.
Founded in 2022, Yuzu Health is building a next-generation third-party administrator (TPA) platform aimed at modernizing the infrastructure behind health insurance operations. The company focuses on replacing legacy systems that slow innovation, increase administrative costs, and limit the ability of health plans to deliver better member experiences.
Yuzu’s platform automates core functions such as claims adjudication, eligibility verification, financial reconciliation, and benefits administration, helping insurers streamline operations and reduce manual workloads. By upgrading these foundational systems, the company enables health plans to launch faster, operate more efficiently, and improve service delivery for employers and members.
The investment will be used to expand engineering capabilities, scale the platform across the U.S., and further automate high-cost workflows—particularly claims processing and reconciliation, which are key bottlenecks in traditional TPA models. The funding reflects growing demand for digital transformation in the multi-billion-dollar health insurance administration market, where efficiency and cost control are increasingly critical.
Click here to read the original news story.
